Alzocin 10 – Alfuzosin Hydrochloride IP 10 Mg (Prolonged Released)
Alfuzosin Hydrochloride IP 10 Mg (Prolonged Released)
Exporter, Distributor Drop shipper to Russia, Brazil, Colombia, Latin America And East Asia
Alzocin 10 contains Alfuzosin Hydrochloride IP 10 mg (Prolonged Release), an alpha-1 adrenergic receptor blocker indicated for the treatment of Benign Prostatic Hyperplasia (BPH). It helps relax the muscles of the prostate and bladder neck, improving urine flow and relieving urinary symptoms associated with an enlarged prostate.
|
Contain |
Alfuzosin Hydrochloride IP 10 Mg (Prolonged Released) |
|---|---|
|
Strength |
10 Mg |
|
Packaging |
10X10TAB |
|
Category |
Categories: Urology |
|
Manufacturer |
Johnlee Pharmaceuticals Pvt. Ltd |
|
Brand |
Alzocin |
Product Overview
Alzocin 10 is a prolonged-release formulation of Alfuzosin Hydrochloride, developed for the effective management of urinary symptoms associated with Benign Prostatic Hyperplasia (BPH). As a selective alpha-1 adrenergic receptor blocker, it helps improve urinary flow and reduce lower urinary tract symptoms caused by an enlarged prostate. The prolonged-release technology ensures sustained drug release, providing consistent symptom relief throughout the day with convenient once-daily dosing.
Alzocin 10 is widely prescribed for men experiencing difficulty in urination, frequent urination, urgency, weak urine stream, and incomplete bladder emptying due to BPH. By improving urinary function without significantly affecting prostate size, it helps patients achieve better comfort and an improved quality of life.
How It Works
Alfuzosin selectively blocks alpha-1 adrenergic receptors located in the smooth muscles of the prostate, bladder neck, and urethra. This relaxation reduces bladder outlet resistance, allowing urine to flow more freely and relieving symptoms associated with Benign Prostatic Hyperplasia. The prolonged-release formulation provides sustained therapeutic action, ensuring consistent symptom control over 24 hours.
Therapeutic Applications
Alzocin 10 may be prescribed for the management of:
- Benign Prostatic Hyperplasia (BPH)
- Lower Urinary Tract Symptoms (LUTS)
- Difficulty in Urination
- Weak Urinary Stream
- Urinary Hesitancy
- Frequent Urination
- Incomplete Bladder Emptying
- Urinary Urgency associated with BPH
Key Benefits
- Prolonged-release formulation for once-daily dosing.
- Improves urine flow and bladder emptying.
- Helps reduce urinary frequency and urgency.
- Relieves lower urinary tract symptoms associated with BPH.
- Supports improved urinary comfort and quality of life.
- Manufactured under stringent pharmaceutical quality standards.
Quality Commitment
Vinix Biopharma is committed to delivering high-quality urology products manufactured under stringent pharmaceutical quality standards. Alzocin 10 undergoes rigorous quality control throughout the manufacturing process to ensure safety, consistency, efficacy, and reliability. Every batch is carefully tested to meet established quality specifications and support optimal patient care.
Storage Information
Store in a cool, dry place below 30°C. Protect from moisture and direct sunlight. Keep out of reach of children.
Disclaimer
Alzocin 10 should be used only under the supervision of a qualified healthcare professional. Dosage and duration of treatment should be determined by the treating physician based on the patient’s clinical condition and therapeutic requirements.




